“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks ...

New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...

Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...

This helps manage migraine symptoms. A 2021 systematic review and meta-analysis compared triptans, ditans, and gepants for migraine treatment. Researchers found that triptans were more effective ...

The device received FDA clearance in the United States in March 2021 for at-home treatment of acute migraine in adults ... his work has focused on new research in the treatment of infectious ...

2021. It works by blocking calcitonin gene-related peptide (CGRP), a protein released by the brain's nerve cells during a migraine attack. For this new study ... "Having a treatment that can ...